4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-20-054055
Options or other derivatives
- Executive VP, Head of R&D acquired 16,666 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ho Tony W Executive VP, Head of R&D | 2020-10-05 | Grant or award · Stock Option (Right to Buy) | +16,666 | 16,666 | D | ||
Loading xslF345X03/doc4.xml…